Walgreens Boots Alliance Inc
NASDAQ:WBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.1), the stock would be worth $12.54 (5% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.1 | $11.98 |
0%
|
| 3-Year Average | 0.1 | $12.54 |
+5%
|
| 5-Year Average | 0.2 | $24 |
+100%
|
| Industry Average | 0.8 | $87.96 |
+634%
|
| Country Average | 3 | $324.78 |
+2 611%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
$17.4B
|
/ |
Jun 2025
$154.6B
|
= |
|
|
$17.4B
|
/ |
Aug 2025
$156.2B
|
= |
|
|
$17.4B
|
/ |
Aug 2026
$158.6B
|
= |
|
|
$17.4B
|
/ |
Aug 2027
$163.2B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 0.1 | -1.6 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62.7B ZAR | 1.3 | 19.4 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR | 0.9 | 25.3 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
38.5B BRL | 1 | 30.2 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
929.3B JPY | 0.6 | 21.8 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
911.6B JPY | 0.8 | 16.6 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 1.7 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.2B CNY | 1 | 16.9 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 0.5 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
574.6B JPY | 0.6 | 12.9 | |
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
482.7B JPY | 0.5 | 15.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 3 |
| 70th Percentile | 5.3 |
| Max | 4 613 320.1 |
Other Multiples
Walgreens Boots Alliance Inc
Glance View
In the world of retail pharmacy, Walgreens Boots Alliance Inc. stands as a formidable player, weaving a complex tapestry that spans across more than two dozen countries. Born from the merger of Walgreens, an iconic American pharmacy chain, and Alliance Boots, a European health and beauty group, this company marries a vast network of retail pharmacies with an integrated healthcare strategy. At the heart of its operations is the retail pharmacy segment, where customers are served both prescription medications and over-the-counter health products alongside a curated selection of wellness and beauty offerings. By integrating in-store pharmacists who administer vaccines and provide health consultations, Walgreens Boots Alliance enhances its core pharmacy business, ensuring that health professionals and strategic store placement work hand-in-hand to deliver comprehensive health solutions. Beyond the familiar aisles of their retail pharmacies, Walgreens Boots Alliance generates additional revenue through its pharmaceutical wholesale division, which supplies medicines and healthcare products to pharmacies, doctors, and hospitals. This segment boosts its financial ecosystem by leveraging strategic partnerships with major pharmaceutical companies, ensuring steady supply chains and competitive pricing. The company's ability to adapt to the digital age further amplifies its operations; through e-commerce platforms and digital health services, it stays attuned to the evolving needs of its clientele. Operating at the intersection of healthcare and retail, Walgreens Boots Alliance is not just a dispenser of medicines but a strategic navigator in the healthcare sector, maneuvering through complex market dynamics to maintain its influential position.